Aleafia Health Inc (DE:ARAH)

Aleafia Health (DE:ARAH) Income Statement


Aleafia Health Income Statement

Last quarter (Q2 2022), Aleafia Health's total revenue was C$12.03M, a decrease of -20.88% from the same quarter last year. In Q2, Aleafia Health's net income was C$-4.47M. See Aleafia Health’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 22Dec 20Dec 19Dec 18Dec 17
Total Revenue
C$ 39.35MC$ 43.12MC$ 44.54MC$ 16.35MC$ 3.33MC$ 15.77K
Cost of Revenue
C$ 23.24MC$ 55.07MC$ 50.15MC$ -4.43MC$ 542.00KC$ 0.00
Gross Profit
C$ 16.10MC$ -11.94MC$ -5.61MC$ 20.78MC$ 2.79MC$ 15.77K
Operating Expense
C$ 36.67MC$ 46.49MC$ 40.00MC$ 44.77MC$ 21.38MC$ 9.71M
Operating Income
C$ -20.57MC$ -58.44MC$ -45.61MC$ -23.98MC$ -18.59MC$ -9.69M
Net Non Operating Interest Income Expense
C$ -8.73MC$ -10.79MC$ -11.64MC$ -5.96MC$ 170.00KC$ 0.00
Other Income Expense
C$ -72.23MC$ -103.50MC$ -192.53MC$ -6.71MC$ -1.12M-
Pretax Income
C$ -101.53MC$ -172.72MC$ -249.78MC$ -36.65MC$ -19.54MC$ -9.69M
Tax Provision
C$ -2.85MC$ -2.85MC$ -2.54MC$ 2.96MC$ -1.01MC$ 0.00
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
C$ -98.67MC$ -169.87MC$ -247.24MC$ -39.61MC$ -18.53MC$ -9.69M
Basic EPS
Diluted EPS
Basic Average Shares
Diluted Average Shares
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
C$ 59.91MC$ 101.56MC$ 90.15MC$ 40.33MC$ 21.92MC$ 9.71M
Interest Expense
C$ 8.73MC$ 10.79M-C$ 6.38MC$ 0.00-
Net Income From Continuing And Discontinued Operation
C$ -98.67MC$ -169.87MC$ -247.24MC$ -39.61MC$ -18.53MC$ -9.69M
Normalized Income
C$ -28.60MC$ -68.06MC$ -49.91MC$ -34.46MC$ -17.38MC$ -9.69M
C$ -92.79MC$ -161.93MC$ -45.61MC$ -23.98MC$ -19.54MC$ -9.69M
C$ -84.13MC$ -149.87MC$ -35.44MC$ -18.07MC$ -17.88MC$ -9.63M
Currency in CAD

Aleafia Health Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis